Consultronixsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-06-30
Share capital
23 332 000,00 PLN
Activity description

Consultronix offers medical technologies, including the Navilas system for digitally navigated retinal laser therapy and ophthalmic devices such as autorefractors and Plusoptix equipment. The company also features DermLite dermatoscopes and Agfa HealthCare PACS and IT solutions.

Registered address
ul. Przemysłowa 17, 32-083 Balice, Poland
Website
consultronix.plWebsite active
Social media
Electronic delivery address
AE:PL-42930-92868-VEJRT-16

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 29.09mMedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD 1.90mMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 26.51mMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 12.70mMedianUSD 541.73kAverageUSD 10.95m

Bank accounts

Registered as a VAT taxpayer on 2023-06-30. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Sep 4, 2023Demerger

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$8,970
De minimis aid (in accordance with Commission Regulation 2023/2831)
$8,740

Tenders

605 tenders recorded as contractor: 249 national ($8,484,041) and 356 EU ($570,390,199).

SubjectAmount
Dostawa produktów leczniczych i wyrobów medycznych oraz leków stosowanych w programach lekowych
–
Dostawa materiałów zużywalnych, czynników sterylizacyjnych na potrzeby Centralnej Sterylizatorni dla Centralnego Szpitala Klinicznego Uniwersytetu Medycznego w Łodzi przy ul. Pomorskiej 251
–
Zakup i dostawy leków
–

Public sector contracts

Consultronix is the contractor in 208 public sector contracts, worth PLN 6.85m in total. They were signed with 87 public buyers.

Public buyerValue
Uniwersytecki Szpital Kliniczny Nr 2 Pum w SzczeciniePLN 353.38
Szpital Miejski Św. Jana Pawła II w ElbląguPLN 812.00
Specjalistyczny Szpital Im. Dra Alfreda SokołowskiegoPLN 450.00
Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej w GryficachPLN 1,238
Uniwersytecki Szpital Kliniczny w PoznaniuPLN 2,750

Public procurement disputes (KIO)

Consultronix has been a party to 4 cases before the National Appeal Chamber (since 2024). It filed 1 appeal (1 dismissed). In 3 cases it joined the proceedings as a participant.

DateCase no.RoleOther partyOutcome
May 14, 2026KIO 1636/26Participant (on authority's side)Szpital Wojewódzki im. Św. Łukasza SP ZOZ w TarnowieDiscontinued
Sep 11, 2025KIO 2978/25AppellantUniwersytecki Szpital Kliniczny nr 1 w LublinieDismissed
Jun 10, 2025KIO 1961/25Participant (on authority's side)Uniwersytecki Szpital Kliniczny nr 1 w LublinieDiscontinued
Feb 16, 2024KIO 307/24Participant (on authority's side)Narodowy Instytut Onkologii im. Marii Skłodowskiej – Curie – Państwowy Instytut BadawczyDismissed

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Robert Władysław Barański – President of the Management Board
Damian Kalita – Vice President of the Management Board
Leszek Jan Piątek – Attorney-in-fact (joint)
Krzysztof Zdzisław Smolarski – Attorney-in-fact (joint)

Manner of representation

The following persons are authorized to submit declarations of will on behalf of the company and to perform all judicial and extrajudicial acts of the company: a) in the case of a one-person management board, the sole member of the management board independently; b) in the case of a multi-member management board, the President of the Management Board acting jointly with a member of the management board or the President of the Management Board acting jointly with a commercial proxy, or a member of the management board acting jointly with a commercial proxy (provided that a commercial proxy is appointed in the company).

Ownership

OwnerSharesShare valueStake
Leszek Jan Piątek (68)
186,656$2,521,015.6740%
Krzysztof Zdzisław Smolarski (70)
279,984$3,781,523.5060%

Beneficial owners

Person

Competitors

Name
SynektikS.A.
Olympus Polskasp. z o.o.
Ascensia Diabetes Care Polandsp. z o.o.
Amadasp. z o.o.
Novamed.PlS.A.
Alstor A. Zwierzynski i Wspólnicysp. z o.o.
Intimexsp. z o.o. + limited partnership
Ursapharm Polandsp. z o.o.
Dermoelitesp. z o.o.
Nova Group A. Chmielewskisp. k.

FAQ

Last updated: 2026-04-23